Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Tensys Medical receives CE mark for TL-400 and TL-300 systems

Tensys Medical has received CE mark for its latest generation non-invasive hemodynamic patient monitoring systems called the TL-400 and TL-300.

This approval allows immediate commercialization of the systems in Europe.

The TL-400 offers physicians with a stream of real-time advanced hemodynamic data that was earlier done with either highly invasive devices or less invasive technologies. It captures patient’s beat-to-beat waveform and blood pressure without usage of needle.

The TL-300, which is already available in the US and Chinese markets provides a stream of real-time beat-to-beat arterial waveform and blood pressure, avoiding the blind-time associated with a deflated or inaccurate cuff.

Claimed to improve overall hemodynamic monitoring, both devices feature a touch-screen user interface.

Tensys COO Jamie Sulley noted the TL-400 and TL-300 represent significant advances in non-invasive, hemodynamic monitoring tools.

"Measuring advanced hemodynamic parameters in a completely non-invasive fashion opens new avenues in critical care as these platforms display vital patient data with almost zero patient risk," Sulley added.